These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20613781)

  • 1. Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients.
    Jiang S; Hsu YH; Venners SA; Zhang Y; Xing H; Wang X; Xu X
    J Hum Hypertens; 2011 May; 25(5):327-33. PubMed ID: 20613781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin-aldosterone system gene polymorphisms and antihypertensive response to irbesartan in Chinese hypertensives.
    Liu H; Zhang S; Jiang S; Mao G; Hong X; Yu Y; Zhang Y; Tang G; Xing H; Xu X
    Methods Find Exp Clin Pharmacol; 2008 May; 30(4):307-12. PubMed ID: 18773126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension.
    Zhang S; Mao G; Zhang Y; Tang G; Wen Y; Hong X; Jiang S; Yu Y; Xu X
    Clin Ther; 2005 Nov; 27(11):1774-84. PubMed ID: 16368448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive Effect of the KCNJ11 Ile337Val Polymorphism and Cigarette Smoking on the Antihypertensive Response to Irbesartan in Chinese Hypertensive Patients.
    Jiang S; Venners SA; Hsu YH; Weinstock J; Wang B; Xing H; Wang X; Xu X
    Am J Hypertens; 2016 May; 29(5):553-9. PubMed ID: 26304961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive effect of angiotensin II type 1 receptor (AGT1R) polymorphisms and plasma irbesartan concentration on antihypertensive therapeutic responses to irbesartan.
    Jiang S; Hsu YH; Venners SA; Zhang Y; Xing H; Wang X; Xu X
    J Hypertens; 2011 May; 29(5):890-5. PubMed ID: 21346624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A coding polymorphism of the kallikrein 1 gene is associated with essential hypertension: a tagging SNP-based association study in a Chinese Han population.
    Zhao W; Wang L; Lu X; Yang W; Huang J; Chen S; Gu D
    J Hypertens; 2007 Sep; 25(9):1821-7. PubMed ID: 17762646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual and joint association of alpha1A-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjects.
    Jiang S; Mao G; Zhang S; Hong X; Tang G; Li Z; Liu X; Zhang Y; Wang B; Xu X; Wang X
    Clin Pharmacol Ther; 2005 Sep; 78(3):239-48. PubMed ID: 16153395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
    Kurland L; Liljedahl U; Karlsson J; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L
    Am J Hypertens; 2004 Jan; 17(1):8-13. PubMed ID: 14700505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.
    Schrader J; Bramlage P; Lüders S; Thoenes M; Schirmer A; Paar DW
    Clin Drug Investig; 2007; 27(11):783-96. PubMed ID: 17914897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ambulatory blood pressure monitoring study of the comparative antihypertensive efficacy of two angiotensin II receptor antagonists, irbesartan and valsartan.
    Mancia G; Korlipara K; van Rossum P; Villa G; Silvert B
    Blood Press Monit; 2002 Apr; 7(2):135-42. PubMed ID: 12048432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
    Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
    Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension.
    Lacourcière Y
    Clin Ther; 2000 Oct; 22(10):1213-24. PubMed ID: 11110232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9 Ile359Leu polymorphism, plasma irbesartan concentration and acute blood pressure reductions in response to irbesartan treatment in Chinese hypertensive patients.
    Chen G; Jiang S; Mao G; Zhang S; Hong X; Tang G; Li Z; Liu X; Zhang Y; Xing H; Wang B; Yu Y; Xu X
    Methods Find Exp Clin Pharmacol; 2006; 28(1):19-24. PubMed ID: 16541193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of monotherapy with irbesartan 150 mg or amlodipine 5 mg for treatment of mild-to-moderate hypertension.
    Neutel JM; Germino FW; Smith D
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):84-9. PubMed ID: 16470487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
    Chrysant SG; Neutel JM; Ferdinand KC;
    J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial.
    Lewin AJ; Weir MR
    Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of single nucleotide polymorphisms of kallikrein 1 gene with cerebral hemorrhage in Changsha Han Chinese].
    Zeng Y; Zhang L; Hu ZY; Yang QD; Liu BQ; Ma MM; Liu YH; Xu HW; Xia J; Du XP; Hu ZP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):316-9. PubMed ID: 20533273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F; Bramlage P; Paar WD
    Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.